Surgical targeting through photo-medicine based localization using Luminomark injection for thyroid surgery

ational Cancer Center0 个研究点目标入组 46 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•1. Thyroid nodules or follicular tumors that are difficult to localize with conventional methods such as CT, ultrasound, and scans, but require surgery
•2. Recurrent or primary thyroid cancer for which surgery is planned, although localization is difficult with conventional methods such as CT, ultrasound, and scan
•3. Parathyroid adenoma or cancer that is difficult to localize with conventional methods such as CT, ultrasound, or scan, but surgery is planned
•4. Cervical tumors that are difficult to localize with conventional methods such as CT, ultrasound, and scans, but require surgery
•5. Patients between the ages of 19 and 80
•6. Patients who voluntarily decided to participate in this clinical study and signed the written informed consent

•1. Those with a history of allergy to ICG (Indocyanine Green)
•2. Pregnant and lactating women
•3. Women of childbearing potential who are expected to become pregnant (menopausal women with at least 12 months of amenorrhea are considered non-fertile women)
•4. Patients with mental illness, those with a history of alcoholism or drug abuse
•5. Those who have participated in other clinical trials within 6 months of participating in this study
•6. A person who is judged by the researcher to be unfit to participate in the research for other reasons
•7. Patients with a history of hypersensitivity to active ingredients and excipients of investigational drugs

发起方

ational Cancer Center